CN101224275B - Chinese traditional medicine for treating chloasma - Google Patents
Chinese traditional medicine for treating chloasma Download PDFInfo
- Publication number
- CN101224275B CN101224275B CN2008100142384A CN200810014238A CN101224275B CN 101224275 B CN101224275 B CN 101224275B CN 2008100142384 A CN2008100142384 A CN 2008100142384A CN 200810014238 A CN200810014238 A CN 200810014238A CN 101224275 B CN101224275 B CN 101224275B
- Authority
- CN
- China
- Prior art keywords
- radix
- blood
- speckle
- chloasma
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 206010008570 Chloasma Diseases 0.000 title claims abstract description 15
- 208000003351 Melanosis Diseases 0.000 title claims abstract description 15
- 239000009636 Huang Qi Substances 0.000 claims abstract description 11
- 238000007796 conventional method Methods 0.000 claims abstract description 6
- 241000628997 Flos Species 0.000 claims description 11
- 239000008517 radix Trichosanthis Substances 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 10
- 239000002994 raw material Substances 0.000 abstract description 4
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 208000037093 Menstruation Disturbances Diseases 0.000 abstract 1
- 206010027339 Menstruation irregular Diseases 0.000 abstract 1
- 241000736199 Paeonia Species 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 108010021119 Trichosanthin Proteins 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 37
- 210000004369 blood Anatomy 0.000 description 37
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 208000019255 Menstrual disease Diseases 0.000 description 5
- 238000010298 pulverizing process Methods 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 230000001815 facial effect Effects 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 241000213006 Angelica dahurica Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010021718 Induced labour Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- -1 Ying Wei Substances 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000001827 electrotherapy Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000002078 massotherapy Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000000712 neurohormone Substances 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000015124 ovarian disease Diseases 0.000 description 1
- 201000004535 ovarian dysfunction Diseases 0.000 description 1
- 231100000543 ovarian dysfunction Toxicity 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- SWGJCIMEBVHMTA-UHFFFAOYSA-K trisodium;6-oxido-4-sulfo-5-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2-sulfonate Chemical compound [Na+].[Na+].[Na+].C1=CC=C2C(N=NC3=C4C(=CC(=CC4=CC=C3O)S([O-])(=O)=O)S([O-])(=O)=O)=CC=C(S([O-])(=O)=O)C2=C1 SWGJCIMEBVHMTA-UHFFFAOYSA-K 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating chloasma; the invention is a medicament prepared by the following raw materials by weight proportion through a conventional method: 5-8g of angelica, 8-10g of safflower, 8-10g of figwort, 5-8g of radix bupleuri, 5-10g of trichosanthin, 8-10g of red paeonia, 5-10g of rhizoma anemarrhenae, 10-20g of radix astragali, 8-12g of fried atractylodes rhizome, 6-10g of prepared nutgrass galingale rhizome and 1.5-3g of liquorice. The invention has rapid curative effect, short treatment course, high cure rate, low cost but no toxic and side effects at all; through the clinical application of patients, the cure rate reach 95 percent and the total effective rate can reach over 98 percent. Furthermore, the invention has significant treatment effect for the patients with stain and irregular menstruation. .
Description
Technical field
The present invention relates to a kind of Chinese medicine that is used for the treatment of chloasma.
Background technology
Face appearance women is since ancient times all paid much attention to, and especially along with growth in the living standard, people pay close attention to more to face.It is in rising trend that face has the women of chloasma now, though facial long speckle is superficial, brings worry to the patient, influences quality of life.The patient is mostly with the method for the beauty treatment of whitening, through for several times even tens of beautifying whitening massotherapys, speckle have desalinate or disappear, can only the epidermis speckle dispelling, but also can see speckle at short notice again; Also the sub-electrotherapy of using light is freezing, and the speckle of face is burnt, and in the hope of thorough speckle dispelling, the effect that reaches is temporary transient, and the patient is subjected to suffering of flesh, and speckle also can occur at face after a couple of days or several months, the existence in vivo of all uncontrollable melanin of said method.Because pigment can be deposited on each layer of skin, deep mixed, beauty curing can only be controlled surface skin temporarily, and bounce-back.The active drug of brown patch of harnessing the Yellow River at present is few, and effect is also undesirable, cures the symptoms, not the disease the price height by beautifying whitening cosmetics speckle dispelling.
Summary of the invention
The objective of the invention is in order to solve the deficiency of above-mentioned technology, provide a kind of have evident in efficacy, short treating period, non-stimulated to gastrointestinal, cheap, and the Chinese medicine of the treatment chloasma that has no side effect.
For achieving the above object, a kind of Chinese medicine for the treatment of chloasma is characterized in that the medicament of being made according to a conventional method by the material medicine that following weight proportion is formed: Radix Angelicae Sinensis 5-8g, Flos Carthami 8-10g, Radix Scrophulariae 8-10g, Radix Bupleuri 5-8g, Radix Trichosanthis 5-10g, Radix Paeoniae Rubra 8-10g, Rhizoma Anemarrhenae 5-10g, Radix Astragali 10-20g, Rhizoma Atractylodis Macrocephalae (parched) 8-12g, Rhizoma Cyperi (processed) 6-10g, Radix Glycyrrhizae 1.5-3g.
The solution of the present invention is to suit the remedy to the case at the pathogenesis of chloasma, adopts Chinese herbal medicine to form, and utilization fills blood, and is soothing the liver strongly fragrant, drives blood stasis, the method for tissue regeneration promoting flesh, and through clinical prolonged application with update, effect is remarkable, and does not rebound.Because the medicine source is a natural plants, the Chinese medicine source is wide, and preparation is simple, and cost is low, makes easily, and is easy to use, takes gastrointestinal is had no adverse reaction, and without any side effects, through the clinical practice checking, cure rate can reach more than 90.54%, effective percentage 98.86%.
Chinese medicine of the present invention adopts Chinese angelica blood supplementing and blood, and menstruction regulating and pain relieving breaks stagnant blood and supports fresh blood, moistening five ZANG-organs, and the increase immunologic function, and can the diffusing short QI and blood of temperature respectively return to some extent, the speckle dispelling appearance renews; The Flos Carthami promoting blood circulation to restore menstrual flow, blood stasis removing is moisturized, alleviating pain and detumescence, the stasis of speckle rash, the power of clots absorbing fast sharp four reaches.Energy facedown speckle element; The Radix Scrophulariae YIN nourishing and the production of body fluid promoting, eliminating fire and detoxication is separated the speckle poison especially, disperses the panacea of melanin; The Radix Bupleuri expelling pathogenic factors from the exterior expels the heat-evil, dispersing the stagnated live-QI to relieve the stagnation of QI, and the regulating menstruation row stagnates, and the lifting of balance zang-fu organs qi movement makes QI and blood and smooth, helps its medicine to control melanic silt and ties and duplicate; The Radix Trichosanthis clearing away heat and promoting production of body fluid, detumescence and apocenosis can be gone into blood system, repercussive blood, the heat radiation knot, granulation promoting is put on flesh, and quickens the expansion of regeneration Skin Cell, makes newborn skin substitute the speckle element; The Radix Paeoniae Rubra removing heat from blood and promoting blood circulation, the heat in blood that disappears promoting the circulation of blood stagnates, clear and coherent passages through which vital energy circulates, dispelling malignant blood, the speckle removing rash among rudiment, is the key medicine of speckle with the melanin antagonism; Rhizoma Anemarrhenae clearing away heat-fire, nourshing Yin and drynsessmoistening prescription, help its medicine to resist the melanin growth; The Radix Astragali, Rhizoma Atractylodis Macrocephalae (parched) air making-up and spleen enlivening, promoting pus discharge and tissue regeneration strengthening, consolidating superficial resistance is set upright, the people's that can go directly skin table muscle.Modern medicine study, the Radix Astragali have the raising lymhocyte transformation rate, promote hemorheology, enhancing body's immunological function, and collaborative all medicines are set upright and are driven speckle and grow skin; The Rhizoma Cyperi (processed) dispersing the stagnated live-QI to relieve the stagnation of QI, menstruction regulating and pain relieving, the good medicine of regulating the flow of vital energy has sharp three warmers, separates six kinds of stagnation-syndromes, and the Directorate-General DG of the disorder of QI of logical 12 warps makes the whole body mechanism of qi fluent, and QI and blood is closed suitable, can help healthy energy, the speckle of getting rid of evils; Hundred poison are separated in the Radix Glycyrrhizae invigorating the spleen and replenishing QI, concoct all medicines, have complementary functions.Supply healthy energy, spirit, QI and blood, Ying Wei, body fluid, the nephroyin and nephroyang at the mansion of patient's the vital organs of the human body and strange perseverance are run well, and just the interior trace element of neuro humor, reticuloendothelial system, immune system, body said of modern medicine and nucleoprotein etc. can be constant relatively.Have only healthy energy the pathogen of speckle element could be dispersed enough.Full side plays QI replenishing and blood harmonizing altogether, soothing the liverly reaches strongly fragrantly, drives the silt speckle removing, treating both the principal and secondary aspects of a disease can directly produce curative effect to hypophysis and hypothalamus, progressively improves ovarian dysfunction, make and reappear rule menstrual period, amount, color, matter recover normal, the compensation of thoroughly correcting the body disorder, and control melanocyte and gonadal hormone steadily grow and wither away, patient face portion skin lesion place melanin is dissipated, the regeneration Skin Cell is expanded rapidly, and newborn skin substitutes chloasma, and slick skin colour and elasticity are moistened in reproduction.
The specific embodiment
The invention will be further described below in conjunction with embodiment.
Embodiment 1: a kind of Chinese medicine for the treatment of chloasma, the medicament that the material medicine of being made up of following weight proportion is made according to a conventional method: Radix Angelicae Sinensis 5g, Flos Carthami 10g, Radix Scrophulariae 8g, Radix Bupleuri 8g, Radix Trichosanthis 5g, Radix Paeoniae Rubra 10g, Rhizoma Anemarrhenae 5g, Radix Astragali 20g, Rhizoma Atractylodis Macrocephalae (parched) 8g, Rhizoma Cyperi (processed) 10g, Radix Glycyrrhizae 1.5g.Radix Angelicae Sinensis, Flos Carthami, Radix Scrophulariae, Radix Bupleuri are pulverized and mixed after the medicinal liquid that decocts Radix Trichosanthis, Radix Paeoniae Rubra, the Rhizoma Anemarrhenae, the Radix Astragali, Rhizoma Atractylodis Macrocephalae (parched), Rhizoma Cyperi (processed), Radix Glycyrrhizae concentrates, pulverizing, preparation again, 20 days take is a course of treatment, oral three times of patient every day.The present invention has double the effecting a permanent cure of taking stopgap measures, and is difficult for recurrence, and the cure rate height has no side effect, and the patient to mottle patient and menoxenia has notable therapeutic effect in addition.
Embodiment 2: a kind of Chinese medicine for the treatment of chloasma, the medicament that the material medicine of being made up of following weight proportion is made according to a conventional method: Radix Angelicae Sinensis 6g, Flos Carthami 8g, Radix Scrophulariae 9g, Radix Bupleuri 5g, Radix Trichosanthis 8g, Radix Paeoniae Rubra 8g, Rhizoma Anemarrhenae 10g, Radix Astragali 15g, Rhizoma Atractylodis Macrocephalae (parched) 10g, Rhizoma Cyperi (processed) 6g, Radix Glycyrrhizae 3g.Radix Angelicae Sinensis, Flos Carthami, Radix Scrophulariae, Radix Bupleuri are pulverized and mixed after the medicinal liquid that decocts Radix Trichosanthis, Radix Paeoniae Rubra, the Rhizoma Anemarrhenae, the Radix Astragali, Rhizoma Atractylodis Macrocephalae (parched), Rhizoma Cyperi (processed), Radix Glycyrrhizae concentrates, pulverizing, preparation again, 20 days take is a course of treatment, oral three times of patient every day.
Embodiment 3: a kind of Chinese medicine for the treatment of chloasma, the medicament that the material medicine of being made up of following weight proportion is made according to a conventional method: Radix Angelicae Sinensis 8g, Flos Carthami 9g, Radix Scrophulariae 10g, Radix Bupleuri 6g, Radix Trichosanthis 10g, Radix Paeoniae Rubra 9g, Rhizoma Anemarrhenae 8g, Radix Astragali 10g, Rhizoma Atractylodis Macrocephalae (parched) 12g, Rhizoma Cyperi (processed) 8g, Radix Glycyrrhizae 2.5g.Radix Angelicae Sinensis, Flos Carthami, Radix Scrophulariae, Radix Bupleuri are pulverized and mixed after the medicinal liquid that decocts Radix Trichosanthis, Radix Paeoniae Rubra, the Rhizoma Anemarrhenae, the Radix Astragali, Rhizoma Atractylodis Macrocephalae (parched), Rhizoma Cyperi (processed), Radix Glycyrrhizae concentrates, pulverizing, preparation again, 20 days take is a course of treatment, oral three times of patient every day.
Take following method to be prepared into capsule preparations:
1, gets the raw materials ready: each raw medicinal material is selected, after the roguing, cleaning, drying, by weight ratio each raw material got all the ready.
2, pulverize: Radix Angelicae Sinensis, Flos Carthami, Radix Scrophulariae, Radix Bupleuri are pulverized, crossed 100 mesh sieves.
3, decocting and concentrating: all the other raw material waters decoct in will filling a prescription, and decoct successively 3 hours, and medicinal liquid is taken out; Decoct with water 2 hours again, medicinal liquid is taken out; Decoct with water 1 hour again, medicinal liquid is taken out; The medicinal liquid of above-mentioned three decoctions is mixed, be condensed into fluid extract.
4, mixing, drying: Radix Angelicae Sinensis, Flos Carthami, Radix Scrophulariae, the Radix Bupleuri powder of pulverizing added in the above-mentioned concentrated fluid extract carry out mixing, dried.
5, pulverizing, preparation: pulverize and make the fine powder mixing, incapsulate and make capsule preparations.Instructions of taking and consumption: per day for adults 3 times, each 4,20 days is a course of treatment.Be not taken by pregnant women.
Analyze according to the clinical exploratory developments of decades and thousands of routine patient's laboratory observation, its main cause of the formation of chloasma is that asthenia of qi and blood is held concurrently due to the qi stagnation blood stasis, is broadly divided into two classes:
One class: asthenia of qi and blood becomes silted up and is cardinal symptom person, and theory of Chinese medical science is thought: " deficiency of vital energy is this, and blood deficiency is mark " deficiency of vital energy then promotes unable, blood must stagnate and not all right, and congestion does not remove, and fresh blood is difficult gives birth to, Tianjin blood just can not soak into outer, and the flourish bones of the body collectively of supporting is so there be saying of " Rong Ze being not dim " and " general rule is not dim ".Modal is women more than 35 years old, and about 79% long speckle patient falls ill after this age bracket.On physiological function, after the women to 35 year old, body internal organs fortuneization function day by day goes down, the metabolism function is in downward trend, through giving a birth post-abortion the fatigue of losing blood, anger is got angry unavoidably, if do not note nutrition supply, invigorating QI and blood, the DNA of body hemopoietic just can not get dividing timely and duplicates, the anemia spleen is then empty, and blood deficiency gas must be empty, and deficiency of vital energy blood then becomes silted up, become silted up and fire-transformation, fire is practiced into dim.This class patient speckle element mostly is distributed in around the mouth or two cheeks, whole body fatigue and weakness; Menoxenia, through measuring gradual minimizing, color is purple or dim, and matter is rare, pale tongue without fur, thready and rapid pulse or stringy and thready pulse.Observe according to the patient who goes to a doctor, the unmarried crowd of adolescence never is the women of overcurrent, induced labor, and gas is blood trouble almost none long speckle of not decreasing not.This just illustrates that melanic power and QI and blood power are closely related.
Two classes: qi stagnation blood stasis, because work strain, life stress is big, the mood anxiety, feelings will is unsuccessful and angry, and anger is impairing the liver then, as " treatise on blood trouble " cloud: the liver belonging to wood, wood gas dashes and bar reaches, unlikely hold back strongly fragrant, then blood is possible, if disorder of emotion, irritability depression, functional activity of QI being not smooth, then blood is capable is obstructed, and qi stagnation blood stasis takes place.Common clinically is menoxenia, cyclomastopathy etc., and the sickness rate of the long speckle of above-mentioned gynaecopathia patient is about 67%, this shows that qi stagnation blood stasis also is one of main root that causes on long speckle, long speckle patient Chang You is through two mammary swelling pains in preceding menstrual period, through measuring obvious minimizing, color is purple or dim, and piece is arranged, menses are discharged not smooth, the area of facial area speckle constantly enlarges simultaneously, and pigment is deepened gradually, particularly serious symptom dysmenorrhea patient, also have the facial area speckle obviously plain even be cyan, pigmentation can reach subcutaneous tissue deeply.Its patient's body of the tongue is dim red or purple red speckle is arranged, and has substantially all that sublingual vein is angry to be opened.The pathogenesis that this shows speckle mainly is that empty folder is retarded by silt, so to mend the logical double group medicine plan side that executes.
Be the preparation name with the present invention to remove the speckle menstruation-regulating capsules clinically, take that its effect is remarkable at the mottle patient of all ages and classes, different symptoms, the different courses of disease and the patient of menoxenia.
Criterion of therapeutical effect:
Cure: mottle disappears, and facial area is as before bright and clean, and menstruation is risen as scheduled, and amount, color, matter are normal.
Effectively: the mottle desalination, area obviously dwindles, and menstruation recovery is roughly normal.
Invalid: mottle disappears below 1/3, and menstruation is still undesired.
The clinical treatment statistical data of speckle dispelling curative effect of the present invention is as follows:
| The course of treatment | The example number | Cure | Effectively | Invalid |
| 3 courses of treatment of 2 courses of treatment, 1 course of treatment | 540 2280 860 | 420 2078 834 | 107 182 17 | 13 20 9 |
| Add up to | 3680 | 3332 | 306 | 42 |
Clinical chloasma and menoxenia 3680 examples of being used for the treatment of, cure rate reaches more than 90.54%, effective percentage 98.86%.
Claims (1)
1. Chinese medicine for the treatment of chloasma, it is characterized in that the medicament made according to a conventional method by the material medicine that following weight proportion is formed: Radix Angelicae Sinensis 5-8g, Flos Carthami 8-10g, Radix Scrophulariae 8-10g, Radix Bupleuri 5-8g, Radix Trichosanthis 5-10g, Radix Paeoniae Rubra 8-10g, Rhizoma Anemarrhenae 5-10g, Radix Astragali 10-20g, Rhizoma Atractylodis Macrocephalae (parched) 8-12g, Rhizoma Cyperi (processed) 6-10g, Radix Glycyrrhizae 1.5-3g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100142384A CN101224275B (en) | 2008-01-30 | 2008-01-30 | Chinese traditional medicine for treating chloasma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100142384A CN101224275B (en) | 2008-01-30 | 2008-01-30 | Chinese traditional medicine for treating chloasma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101224275A CN101224275A (en) | 2008-07-23 |
| CN101224275B true CN101224275B (en) | 2010-09-22 |
Family
ID=39856620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100142384A Expired - Fee Related CN101224275B (en) | 2008-01-30 | 2008-01-30 | Chinese traditional medicine for treating chloasma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101224275B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104397537A (en) * | 2014-12-18 | 2015-03-11 | 威海百合生物技术股份有限公司 | Health-care food capable of eliminating pigmentation |
| CN105056004B (en) * | 2015-07-16 | 2018-12-18 | 高永学 | A kind of Chinese medicine composition for treating chloasma |
| CN105394267A (en) * | 2015-11-10 | 2016-03-16 | 王云 | Blood-pressure-lowering and blood-sugar-lowering tea and application thereof |
-
2008
- 2008-01-30 CN CN2008100142384A patent/CN101224275B/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| 江 超,赵新萍,梁桂萍.黄褐斑证治心得.辽宁中医药大学学报8 4.2006,8(4),36-37. |
| 江 超,赵新萍,梁桂萍.黄褐斑证治心得.辽宁中医药大学学报8 4.2006,8(4),36-37. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101224275A (en) | 2008-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101670076B (en) | Traditional Chinese medicine composition for treating disease of chronic nephritis and preparation method thereof | |
| CN101502634B (en) | Chinese medicinal composition for treating uterine blood flow and preparation method thereof | |
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN103041282A (en) | Traditional Chinese medicine for treating deficiency of spleen and kidney and preparation method of medicine | |
| CN101934052B (en) | Medicament for treating facial chloasma and preparation method thereof | |
| CN102240380B (en) | Traditional Chinese medicine preparation for treating senile vascular dementia | |
| CN100591352C (en) | Traditional Chinese medicine for treating nerve function coloboma due to injury of brain and brain surgery and its preparation method | |
| CN103536758A (en) | Traditional Chinese medicinal composition for treating night sweat due to yin deficiency | |
| CN103006979A (en) | Chinese medicinal composition for treating nephrotic edema | |
| CN102512632A (en) | Chinese herbal composition for treating abnormal menstruation | |
| CN102940785B (en) | Traditional Chinese medicine composition for treating vertigo | |
| CN103127472A (en) | Traditional Chinese medicine compound for refractory insomnia | |
| CN101224275B (en) | Chinese traditional medicine for treating chloasma | |
| CN104688932A (en) | Traditional Chinese medicine preparation for postmenopausal osteoporosis and preparation method | |
| CN104225166A (en) | Chinese medicine composition for treating amenorrhea and preparation method thereof | |
| CN101428114B (en) | Medicament for treating chronic hepatitis B, cirrhosis and liver ascites | |
| CN101129736A (en) | Traditional Chinese medicine composition for treating climacteric syndrome | |
| CN104721644A (en) | Traditional Chinese medicine preparation for knee osteoarthritis and preparation method of traditional Chinese medicine preparation | |
| CN104524479B (en) | A kind of Chinese medicine composition for treating premenstrual syndrome and preparation method thereof | |
| CN103041228A (en) | Traditional Chinese medicine composite for treating myasthenia gravis | |
| CN103028089A (en) | Traditional Chinese medicine composition for treating waist pains of middle-aged and old people | |
| CN103610893B (en) | A kind of Chinese medicine for the treatment of coronary heart disease | |
| CN102600414B (en) | Chinese medicinal composition for treating cervical spondylosis | |
| CN101757396B (en) | Traditional Chinese medicine composition for treating deficiency of kidney qi and impotence and spermatorrhea and preparation method thereof | |
| CN104840891A (en) | Traditional Chinese medicine preparation used for treating alcoholic cardiomyopathy and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100922 Termination date: 20110130 |